🇺🇸 FDA
Pipeline program

SC291

SC291-102

Phase 1 mab active

Quick answer

SC291 for Lupus Erythematosus is a Phase 1 program (mab) at Sana Biotechnology with 1 ClinicalTrials.gov record(s).

Program details

Company
Sana Biotechnology
Indication
Lupus Erythematosus
Phase
Phase 1
Modality
mab
Status
active

Clinical trials